Evidence map›Paper›PMID 40221390›Full record

ArticleMedical physics2025

Model observer task-based assessment of computed tomography metal artifact reduction using a hip arthroplasty phantom.

Grant Fong, Steven Izen, Andrew Primak, Nancy Obuchowski, Wadih Karim, Brian Herts, Naveen Subhas

Abstract read
In one paragraph

Article in Medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Grant FongImaging Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Steven IzenDepartment of Mathematics, Applied Mathematics and Statistics, Case Western Reserve University, Cleveland, Ohio, USA.
Andrew PrimakSiemens Healthineers USA, Malvern, Pennsylvania, USA.
Nancy ObuchowskiDepartment of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA.
Wadih KarimImaging Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Brian HertsImaging Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Naveen SubhasImaging Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Funding

Siemens Medical Solutions USA
6 · The paper itself

Abstract

backgroundThe United States Food and Drug Administration (FDA) recently published a model observer-based framework for the objective performance assessment of computed tomography (CT) metal artifact reduction (MAR) algorithms and demonstrated the framework's feasibility in the low-contrast detectability (LCD) task-based assessment of MAR performance in a mathematical phantom. PURPOSE: This study investigates the feasibility of the model observer-based framework in LCD task-based assessment of MAR performance using a physical arthroplasty phantom, results of which were then compared with the performance of human observers.

methodsA phantom simulating a unilateral hip prosthesis was designed with a rotatable insert containing a metal implant (cobalt-chromium spheres attached to titanium rods) and 16 unique low-contrast spherical lesions. Each lesion was scanned 100 times on a CT scanner (Somatom Force, Siemens Healthineers) with standard full-dose and half-dose protocols (140 kVp, 300 and 150 quality reference mAs) in each of four different insert rotations to supply 100 pairs of signal-present (lesion) and signal-absent (background) images needed for model observer analyses. Lesion detectability (d') using channelized Hotelling observers (CHO) was optimized by testing different image transformation techniques and channel selection (Gabor and Laguerre-Gauss [LG]) and calculated for each lesion reconstructed with and without iterative MAR (iMAR, Siemens Healthineers). Linear regression was used to assess the d' in each image set. Spearman's correlation was used to compare d' results to human detectability and confidence scores from a previously published human observer study involving the same phantom.

resultsCHO d' measurements using LG channels were less sensitive to artifacts than those using Gabor channels and were therefore selected for the LCD assessment. Image masking and thresholding provided more accurate d' by isolating the signal and minimizing background differences. For all lesions, d' values of full-dose iMAR images were significantly greater than those of filtered back projection (FBP) images at full dose (p < 0.001) and half dose (p < 0.001). Additionally, d' values of half-dose iMAR images were significantly greater than those of FBP images at full dose (p = 0.010) and half dose (p < 0.001). The d' values were not significantly different between full-dose and half-dose FBP (p = 0.620) or between full-dose and half-dose iMAR (p = 0.358). Pooling across all lesions, d' measurements were positively correlated with human detection rate (Spearman correlation coefficient = 0.723; p < 0.001) and confidence scores (Spearman correlation coefficient = 0.727; p < 0.001).

conclusionsThe use of CHO in the LCD assessment of MAR performance can be feasibly performed on a physical phantom, and results using this method correlated well with findings from human observers.

Indexed as

Arthroplasty, Replacement, HipArtifactsHip ProsthesisMetalsPhantoms, ImagingTomography, X-Ray ComputedAlgorithmsHumansImage Processing, Computer-AssistedMetalsimage reconstruction (IM‐CT)observer models (IM/TH‐Mathematical/Statistical Foundational skills)quality control and image quality assessment (IM‐CT)

Identifiers

PMID40221390
PMCPMC12149702

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.